The gene responsible for multiple endocrine neoplasia type 1 (MEN1), a heritable predisposition to endocrine tumours in man, has recently been identi®ed. Here we have characterized the murine homologue with regard to cDNA sequence, genomic structure, expression pattern and chromosomal localisation. The murine Men1 gene spans approximately 6.7 kb of genomic DNA and is comprised of 10 exons with similar genomic structure to the human locus. It was mapped to the pericentromeric region of mouse chromosome 19, which is conserved with the human 11q13 band where MEN1 is located. The predicted protein is 611 amino acids in length and overall is 97% homologous to the human orthologue. The 45 reported MEN1 mutations which alter or delete a single amino acid in human all occur at conserved residues, thereby supporting their functional signi®cance. Two transcripts of approximately 3.2 and 2.8 kb were detected in both embryonal and adult murine tissues, resulting from alternative splicing of intron 1. By RNA in situ hybridization and Northern analysis the spatiotemporal expression pattern of Men1 was determined during mouse development. Men1 gene activity was detected already at gestational day 7. At embryonic day 14 expression was generally high throughout the embryo, while at day 17 the thymus, skeletal muscle, and CNS showed the strongest signal. In selected tissues from postnatal mouse Men1 was detected in all tissues analysed and was expressed at high levels in cerebral cortex, hippocampus, testis, and thymus. In brain the menin protein was detected mainly in nerve cell nuclei, whereas in testis it appeared perinuclear in spermatogonia. These results show that Men1 expression is not con®ned to organs aected in MEN1, suggesting that Men1 has a signi®cant function in many dierent cell types including the CNS and testis.
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Introduction
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant cancer syndrome characterized by multiple tumours of the parathyroids, the endocrine pancreas and duodenum, and the anterior pituitary. Patients may have only one type of gland involved or any combination, but in addition, may have other less frequently associated features such as lipomas, carcinoids, and adrenocortical neoplasia (Friedman et al., 1994) . The human MEN1 gene was mapped to 11q13 by linkage analysis in aected families. The recent cloning and characterization of the gene responsible for the MEN 1 syndrome has opened new perspectives towards understanding its pathogenesis ; The European consortium on MEN1, 1997). The gene had been postulated to be a tumour suppressor, as loss of the wild-type allele was found in tumours from MEN1 patients (Larsson et al., 1988) . Additional support for its role as a tumour suppressor gene came from the demonstration of loss of heterozygosity in sporadic tumours (Friedman et al., 1989; Thakker et al., 1989; Sawicki et al., 1992; Debelenko et al., 1997b) and is now con®rmed by the identi®cation of somatic MEN1 mutations Zhuang et al., 1997a, b; Toilat et al., 1997; Debelenko et al., 1997a; Farnebo et al., 1998) . Inactivating mutations have been reported in half of the parathyroid, pituitary and pancreatic tumours which exhibit a concomitant loss of one MEN1 allele. However inactivating mutations or deletions of one allele do not have an eect on the total level of MEN1 gene transcription .
The human MEN1 gene encodes a 610-amino acid protein designated menin with primarily nuclear localization (Guru et al., 1998) . Analysis of DNA from MEN1 patients has identi®ed mutations in all of the nine coding exons, but no genotype-phenotype correlation has been established to date. As menin shows no signi®cant regions of homology with any other protein, little can be deduced about its normal cellular role, other than to suppress neoplasia. Here we have characterized the murine Men1 gene at the genomic level and its expression, in order to identify evolutionary conserved functional domains within menin, and as a step towards elucidating its cellular function and the signi®cance of mutations in MEN1.
Results

The Men1 gene
The chromosomal localization of Men1 was determined by FISH analysis (Figure 1) . A Men1 containing BAC (272J2) was isolated and hybridized to XX metaphases of mouse SV22CD cells. A strong signal was seen in the pericentromeric region of MMU19 only. In the SV22CD cells chromosome 19 is easily identi®ed. While all other chromosomes have been involved in Robertsonian translocations, MMU19 and MMUX are the only remaining telocentric chromosomes.
The exon/intron structure of Men1 was determined by computer alignment of the genomic sequences with the cDNA sequences. The genomic organization of Men1 is essentially the same as that of the human locus, comprising ten exons with the initiating methionine located in exon 2, and the ®rst exon being untranslated ( Figure 2 ). All splice sites conform to the`GT-AG' rule and their relative positions are conserved between the two species, with the exception of the splice donor site of exon 1 and the splice acceptor site of exon 2, which are positioned 116 and 7 nucleotides respectively further downstream in the murine gene (Table 1) . The 15 nucleotides covered in the alternate exon 2 splice form of the human gene are only partially conserved (10/15 nucleotides) in the mouse, but it is¯anked by a consensus splice donor site, indicating that in the mouse they may also represent an alternatively spliced product.
Men1 cDNA and protein A consensus cDNA sequence was generated from sequencing nine EST clones, and in the process a number of potential novel and/or aberrant splice forms were identi®ed (results not shown). The murine cDNA (Genbank accession number AF016398), is over 2608 bp in length (Table 1) and has a high degree of homology with the human cDNA (89% at the nucleotide level across the coding region). The 3' UTR of the Men1 gene, encoded by the downstream part of exon 10, shows less homology (40 ± 45%), and is approximately 100 bases shorter than in the human counterpart. The homology between mouse and human presents as short interspersed stretches of highly conserved sequences. In particular, the last &60 nucleotides 5' of the poly (A) + are almost identical in the two species. The corresponding menin protein is predicted to consist of 611 amino acids (Figure 3 ) and displays 97% amino acid identity overall with human menin. The N-terminal 313 amino acids and the 73 Figure 1 Mapping of Men1 to the pericentromeric region of MMU19 using¯uorescent in situ hybridization (FISH). The mouse BAC 272J2 containing Men1 was biotin labelled and hybridized to metaphase chromosomes from mouse SV22CD cells. The strong positive signal appears as yellow spots on both chromatids of the MMU19 homologues Figure 2 Schematic map of the murine Men1 genomic structure with two cDNAs shown below, and two genomic lambda clones above. Filled boxes indicate exons, and empty boxes indicate introns. The alternatively spliced intron 1 is marked grey, untranslated regions are hatched, and the putative alternate exon 2 splice is grey. The locations of genomic clones is shown, as well as probes used for expression analysis amino acids preceding the termination codon are completely identical between the two species.
The cDNA sequence was generated primarily by analysis of the 3.0 kb insert of IMAGE clone 557658 (Figure 2 ). This cDNA contains EST 105533 and include the poly (A) + -tract through to exon 1. When compared with the other entries in Genbank, it was shown to contain a retained intron 1 which was not present in other ESTs (aa48913 and aa00099 Figure 2 ). The existence of this alternative transcript is supported by Northern blot analysis using dierent parts of the Men1 cDNA as probes (Figures 2 and 4) . In all embryonal and adult mouse tissues two transcripts, 2.8 and 3.2 kb, were detected both with EST aa105533 and with the XhoI fragment covering exons 2 ± 10. However, hybridization with an intron 1 probe only detects the larger band, indicating alternative splicing of intron 1. The occurrence of two alternative transcripts diering by the presence or absence of intron 1, was further con®rmed by RT ± PCR performed on mouse brain RNA with primers derived from either side of the intronic sequence (data not shown). The two transcripts dier by roughly 0.4 kb, which corresponds to the 362 bp size of intron 1 determined by sequencing (Table 1 ). The alternative splice form elongates the reading frame by 54 codons. However, no new initiation codon is introduced, and in Western blot analysis on mouses testis only one protein form is seen ( Figure 5 ).
RNA and protein expression
Men1 expression during mouse development was determined by RNA in situ hybridization and Northern analysis (Figures 4 and 6 ). The three dierent probes ( Figure 2 ) used for RNA in situ hybridization gave identical results in all tissues analysed. In sagittal sections of mouse embryos a general and strong expression was evident at day 14 ( Figure 6 ). At a later gestational age (E17) the distribution had become more restricted, with high signals con®ned mainly to the thymus, skeletal muscle, brain, and spinal cord ( Figure 6 ). In selected tissues from postnatal mouse, Men1 was detected at high levels in hippocampus, cerebral cortex, testis, and thymus. Positive hybridization signals were also seen in kidney, spleen, ovaries, adrenal, pituitary, thyroid, heart, liver, and lung. In all of the adult tissues except CNS and testis, the expression was uniform over the organ without preferential involvement of a speci®c cell type.
Northern analysis of embryonal and adult mouse tissues gave similar results as the RNA in situ hybridization studies. Thus Men1 transcription was shown to start early in feotal development and was detected already at gestational day 7 (Figure 4) . Forelimb, gut, head, heart and lung of E13.5 embryos Figure 3 Predicted amino acid sequence of murine and human menin. Amino acids conserved between mouse and human are marked (.), and`7' signi®es an absence of a corresponding amino acid. The position of the epitope recognized by the antibody M1C2 is underlined. Below are indicated the position of constitutional (c) and somatic (s) missense mutations and single amino acid deletions detected in MEN 1 patients Agarwal et al., 1997; Bassett et al., 1998; Teh et al., 1998) and sporadic parathyroid Farnebo et al., 1998) , pancreatic-duodenal (Toilat et al., 1997; Zhuang et al., 1997b) and pituitary tumours. For some amino acids more than one mutation was found, and the number is given in parenthesis (2 or 3) Uppercase and lowercase letters denote exonic and intronic sequences, respectively. *Indicates that the 5' end of exon 1 has not yet been determined
The murine Men1 gene C Stewart et al all showed expression of Men1 (not shown). On the adult mouse tissue Northern prepared from polyA+RNA Men1 was detected in all tissues analysed except skeletal muscle (Figure 4 ). Men1 expression was also detected on Northern analysis of total RNA from adult lung, liver, spleen, heart, brain, kidney, intestine, muscle, ovary and testis (not shown). Expression was further characterized at the protein level using the polyclonal antibody M1C2 raised against a peptide within menin (Figure 3) . On Western blots M1C2 detected a single protein product of approximately 75 kD in rodent testis ( Figure 5 ). Immunohistochemistry performed on adjacent sections from the adult mouse tissues which had shown the highest Men1 mRNA levels with mRNA in situ hybridization, i.e. brain and testis, showed positive protein staining with a similar cellular distribution as the mRNA signal. The antibody staining in brain was con®ned mainly to nerve cell nuclei, with the strongest labelling of pyramidal nerve cells in the hippocampus (Figure 7) . In testis, very strong in situ hybridization signals were seen over small-sized cells on the luminal side, presumably spermatogonia, in a subpopulation of the seminiferous tubuli. In adjacent sections these tubuli also displayed a positive antibody staining (Figure 7) . However, in contrast to the brain, the labelling in testis was strictly perinuclear (Figure 7) .
Discussion
The MEN1 gene shows a high degree of conservation between mouse and human. The murine homologue was mapped to the pericentromeric region of MMU19, the syntenic region of human 11q13 where the human MEN1 gene is located. It is also known to contain several murine homologues of genes in human 11q13 (Shows et al., 1996) . The genomic organization of Men1 is essentially the same as that of the human locus. At 6.7 kb the mouse gene is slightly smaller than the approximately 8 kb human gene (extending to about the same position 940 bases upstream of the exon 1 donor site, Genbank entry HSU93237). In mouse two transcripts, with and without intron 1, are regularly detected in both embryonal and adult tissues.
Comparison of the predicted amino acid sequences of the murine and human menin proteins points to the possibility of two potential functional domains, implicated by regions of amino acid identity, which are separated by a region of divergent sequence. The larger conserved domain consists of the N-terminal 313 amino acids whilst the second domain encompasses the 73 amino acids preceding the termination codon. Between these putative functionally important parts of the menin protein lies a region of 225 amino acids (residues 314 ± 538) which displays a reduced degree of conservation (91% identity). Of the 20 amino acid substitutions in this`divergent' region, only three are conservative (G399S, D473E and S509G), suggesting that variability in this region may have a less dramatic eect on protein function. Moreover, this region of protein divergence can be arbitrarily subdivided further, since the portion containing the last 35 amino acids (residues 504 ± 538) shows only 63% identity. An additional change within this stretch is a glycine insertion at codon 529 in the mouse, thus making the murine protein one amino acid longer than the human menin.
Missense mutations associated with MEN1 presumably occur at functionally signi®cant amino acids, thus we have used the conservation between the menin homologues to evaluate 40 missense mutations and ®ve mutations deleting one amino acid recently reported in the Heppner et al., 1997; Farnebo et al., 1998; Toilat et al., 1997; Zhuang et al., 1997a,b) . All of these residues are identical in murine menin, thereby supporting the contention that loss of protein function occurs upon substitution of these conserved amino acids (Figure 3 ). Twenty-six of these mutations lie in the ®rst 186 amino acids (14 would be expected if they were distributed equally along the protein), which adds weight to the notion that the N-terminal region of menin, which is identical in human and mouse, forms a functionally signi®cant domain. A second isoform, containing an additional ®ve amino acids, is postulated to occur in humans through alternate splice donor site usage at the end of exon 2 . Notably in the mouse, only 3/5 of the additional amino acids encoded by the alternate splice form are conserved (human: WSPVG; mouse: WSQTG). It is tempting to speculate therefore that these putative longer isoforms of menin rarely occur since there has been less evolutionary pressure to conserve the alternately spliced regions.
Mouse Men1 RNA was observed in all tissues tested, as well as in whole mouse embryos during development. The overall expression pattern of Men1 was very similar to its human counterpart. Two major dierences were observed. The ®rst one concerns the mRNA expression in muscle. Contrarily to human, on Northern blots mouse Men1 mRNA was barely detectable in skeletal muscle. However on total RNA Northerns a clear Men1 signal was detected. This discrepancy might be related to the eciency of Men1 RNA maturation in dierent tissues. The second dierence is the evidence for two alternative transcripts in the mouse that dier by the presence of intron 1 in the 5' untranslated region of the larger RNA species. Such an alternatively spliced mRNA has not been observed in human tissues. Since the presence of intron 1 would give rise to a human mRNA approximately 500 bp larger than the already described one , and would thus be easily detectable, one may assume that such a transcript is not in major abundance in human, if it exists. The production of dierent transcripts by alternative splicing of pre-mRNAs is a widespread phenomenon. In many instances such dierences have been demonstrated to result in functional dierences , showing that the hybridization signal initially is widespread, and later becomes more restricted. Brain (Br), spinal cord (Sc), skeletal muscle, thymus (Th), fat (Fa), lung (Lu), intestine (In), heart (He), liver (Li), dorsal root ganglia (DRG) among the protein isoforms generated by this process. However, it is not rare that mRNA species dier by their untranslated ends, in particular their 5' end like in the case of the mouse Men1 gene described here. We have observed tissue-speci®c variation in the ratio between the two major Men1 mRNA species, but it is striking that both the 3.2 and the 2.8 kb messages are present in every case where the gene is expressed. In this sense, it makes Men1 dierent from genes like c-fgr where dierential promoter utilization and alternative splicing of the 5' untranslated exons give rise to several mRNA species that dier only in their 5' untranslated regions, but are characteristic of discrete cell types (Link et al., 1992) . It would be interesting to investigate whether the two major Men1 transcripts have dierent translation potential, like in the case of the copper-zinc superoxide dismutase gene (SOD1). 5' variants of SOD1 mRNAs are dierentially expressed in various stages of male germ cells and have been shown to dier by their ability to associate to polysomes, and thus to be translated eciently (Gu et al., 1995) .
Men1 gene activity starts early in foetal development with general expression at high levels, whereafter the pattern becomes more tissue-speci®c. The expression is seen in, but not con®ned to organs typically aected in MEN1. This suggests that Men1 has a more general function in many dierent cell types, including the nervous system, testis, ovaries, and kidney. The expression in testis and ovaries is of particular interest considering the phenotype of two compound heterozygotes for MEN1 (Brandi et al., 1993) . In addition to developing MEN1 related tumours both patients were infertile. The man had idiopathic oligospermia and non-motility of spermatozoa although the testicular volume was normal. The female patient had normal ovulatory cycles with no response to gonadotropin stimulation but developed premature menopause. The expression of Men1 in several dierent nerve cell populations, including pyramidal neurons in the hippocampus and cortical neurons, is also noteworthy, even though the lack of functional MEN1 did not result in a discernible neurological phenotype (Brandi et al., 1993) . However, transgenic animal models may be needed in order to provide a more sensitive way of exploring the impact of loss of Men1 in the nervous system.
Materials and methods
Chromosome mapping
A mouse BAC library (purchased from Research Genetics) constructed from mouse strain 129 was screened with a human MEN1 cDNA probe containing the whole coding Figure 7 Immunohistochemistry for menin in mouse brain (A1-A3) and testis (B1-B3). Sections incubated with the antibody (A2, A3, B2, B3) and double labelled with DAPI (A1, B1) show that in the hippocampus (A1, A2), virtually all large nerve cell nuclei display positive staining (white arrow), whereas the smaller and more dense glia cells are unstained (gray arrow). In higher magni®cation (A3) a clear staining is seen in the nucleus, with exception for the nucleolus. In the testis (B1-3) the labelling is strictly perinuclear (arrow) in the small-sized cells interspersed in the epithelia and in the lumen of the seminiferous tubulus
The murine Men1 gene C Stewart et al region plus 272 bases of the 3'-untranslated region. The insert from the plasmid pFPGWMEN1 was labelled with 32 P by random priming and hybridized under stringent conditions to the gridded ®lter-bound clones. Following stringent washes and autoradiography, one positive BAC (272J2) was identi®ed, and characterized by STS content and restriction cleavage (to be detailed elsewhere). The BAC was biotin-labelled and used as a probe for FISH analysis as described (The European Consortium on MEN1, 1996) on metaphase chromosomes from mouse SV22CD cells (Baron et al., 1984) . Fluorescence images were captured using a high-performance cooled chargecoupled device (CCD) camera C4880 (Hamamatsu), interfaced to a PC 486DX33 with a Matrox 640 card. All digital image-acquiring, processing, and analysis functions were accomplished by means of an Alcatel software package (Fluogen). Chromosomal localization was based on scoring a minimum of ten metaphases from two dierent experiments.
cDNA characterization
Using the BLAST algorithm (Altschul et al., 1990) , 21 entries matching the human MEN1 sequence were identi®ed in the Genbank Murine Expressed Sequence Tag (EST) database. From these a partial murine composite cDNA was assembled using the Mac Vector sequence analysis program. The murine cDNA was further extended by completely sequencing 9 of these IMAGE/EST clones: 608138/aa168218; 478494/aa049922; 466652/ aa031132; 406200/w83869; 331220/w14310; 402210/ w76863; 557658/aa105533; 466081/aa034688; and 479252/ aa048913 (Genome Systems Inc.). The cDNA sequence was obtained primarily from sequence data generated from 557658/aa105533 and supported by sequence from 608138/ aa168218. The consensus sequence derived was then used to design oligonucleotides (Table 2) for con®rmation of the cDNA and determination of the genomic structure by sequencing of genomic clones.
Genomic characterization
Clones for genomic sequencing were isolated by screening a murine 129SV genomic DNA library cloned in lFixII (Stratagene) with a human MEN1 cDNA. The EcoRI/KpnI fragment of IMAGE clone 592097/EST AA157873 was 32 Plabelled using a Megaprime labelling kit (Amersham), and hybridized to plaque lifts on Hybond-N ®lters using the method of Church and Gilbert (1984) . After washing the ®lters under reduced stringency, seven positive clones were identi®ed, plaque puri®ed and the DNA extracted as described (Chisholm, 1989) . Two clones (l2ii and l6i) were determined to encompass the majority of Men1 based on restriction analysis and Southern hybridization with oligonucleotide probes from exons 2 and 10 (data not shown).
The sequence of the entire Men1 gene was then determined by sequencing clones l2ii and l6i with vector and internal primers using Applied Biosystems Incorporated (ABI) dye terminator sequencing kits according to the manufacturer's speci®cations. Overlapping fragments and sequences were generated by two main strategies. Firstly, primers previously designed from cDNA sequences (both human and mouse) were used to directly sequence the clones, in addition to generating and end-sequencing PCR fragments generated using eLONGase kits (Gibco/BRL). Secondly, several key restriction fragments were subcloned into pBluescript KS-. These fragments included: XbaI (Vector T3/T7 ± Intron 4); XcmI (Intron 1 ± Intron 2); XhoI (Exon 2 ± Exon 10); XbaI (Intron 4 ± 3' of gene). In order to close any sequence gaps, the subclones were further analysed by insert truncation utilizing internal restriction sites and subsequent religation and sequencing with vector primers. The authenticity of the lambda clones was con®rmed by genomic PCR using primers derived from the sequence of EST aa105533/IMAGE clone 557658. Introns 2 ± 9 were ampli®ed from total mouse (B6) DNA, giving the same intron sizes as obtained from the sequencing.
Isolation of RNA and Northern blot analysis
RNA was extracted from forelimb, gut, head, heart, and lung, dissected from a pool of 406embryonic day 13.5 embryos (E13.5) using a Pharmacia micro poly(A) + extraction kit. A Northern blot was prepared with 1 ± 2 mg loaded in each lane. Total RNA was isolated from a variety of adult murine tissues including lung, liver, spleen, heart, brain, kidney, intestine, muscle, ovary and testis, and Northern blots were prepared with 20 mg loaded in each lane. Three Northern blots prepared from poly(A) + RNA of total mouse embryos (1 ®lter, Catalogue no7763-1) and adult mouse tissues (2 ®lters, Catalogue no7762-1) were purchased from Clontech. Filters were hybridized and washed under stringent conditions using cDNA probes derived from dierent parts of the Men1 gene. The IMAGE clone 557658/EST aa105533 includes exons 1 ± 10 and intron 1. The`intron 1' probe was a 329 bp DNA fragment obtained by PCR ampli®cation of mouse C57/ B16 DNA using the following primers: 5'-GGTGCCTTGTGTGGGATGTA-3' and 5'-TAAGG-CTCTACCCTCCGCCA-3'. It contains the 5' end of IMAGE clone 557658 (nucl. 35 ± 363). The`XhoI fragment' probe was obtained from the IMAGE clone 557658 (nucl. 761 ± 2157) and covers exons 2 (320 bp 3' of the initiation codon) to 10 (120 bp 5' of the termination codon). The human MEN1 cDNA probe pFPGWMEN1 containing the coding region plus 272 bp of the 3' UTR, as well as the manufacturer's mouse actin and/or Gapdh probes were included as controls of speci®city, quality and loading.
In situ hybridization histochemistry Timed pregnant (n=2) and young adult (n=2) mice (NMRI, B&K Universal AB, Sweden) were killed with carbon dioxide, and the relevant tissues were taken out and frozen on a chuck. Two gestational ages were used in this study; E14 and E17.
In situ hybridization was performed as previously described (Dagerlind et al., 1992) . Brie¯y, three synthetic oligonucleotides were generated: 5'-CGATCCTTGAAGTAGGA-GCGGCTGAGGCTGTTCCATATGA-3' (Oligo 1); 5'-GA-GCTGTCCAGTTTGGTGCCTGTGATGAAGCTGAAGA-GGGACT-3' (oligo 2) and 5'-CTGCTTCTTCATCTG-CACTTGCGACTGTGCCGTGAGTTGCAG -3' (Oligo 3). The three oligonucletides correspond to nts 1350 ± 1389 in exon 2, nts 1735 ± 1758 and 2578 ± 2596 in exons 2 and 3, and nts 5920 ± 5962 in exon 10 of the mouse Men1 S-ATP (NEN, MA, USA) using terminal deoxynucleotidyl transferase (Pharmacia, Sweden) and hybridized to 14 mm un®xed cryostat tissue sections without pretreatment for 16 ± 18 h at 428C. Following hybridization the sections were washed several times in 16SSC at 558C, dehydrated in ethanol and dipped in NTB2 nuclear track emulsion (Kodak, USA). In some cases, sections were exposed to an autoradiographic ®lm (b-max, Amersham, UK) prior to emulsion-dipping. In control sections, the speci®city of each probe was checked by adding a 20-fold excess of cold probe to the hybridization mixture. No positive signal above background was seen in these cases. Several probes unrelated to the Men1 gene, but with similar GC contents, were used as controls. These probes gave nonoverlapping expression patterns compared with the Men1 probes (not shown). In addition Gapdh was used on the dissected adult mouse tissues as control of RNA presence.
Antibody production
For the preparation of antisera with speci®city for human and mouse menin, one peptide was used (Research Genetics Inc., Huntsville, AL, USA). Peptide Gly482-Pro495 (GPRRESKPEEPPPP) was synthesized as a multiple antigenic peptide chemically linked to itself. The corresponding amino acid sequence is completely conserved between the murine and human menin proteins. New Zealand White rabbits were immunized with this peptide conjugate, followed by ®ve boosts (one every 4 weeks). Two sera were obtained one of which (M1C2) was further tested by Western blotting.
Western blotting
Protein was isolated from fresh frozen mouse and rat testis using standard methods. Protein extracts were separated by SDS ± PAGE as described by Laemmli (1970) , at a concentration of 7.5% polyacrylamide and using 20 mg of protein per lane. Western transfer was performed according to Towbin et al. (1979) . The ®lters were incubated at 48C O/N with the antiserum diluted to 1 : 2000 in TBS containing 4% NFDM, 0.5% rat serum, 2% horse serum, 0.1% Tween 20 and 0.1% Triton X100. After washing in TBS 0.1% Tween 20, the protein was detected with peroxidase-coupled secondary antibody and enhanced chemiluminiscent detection (ECL, Amersham).
Immunohistochemistry
Men1 was detected with the polyclonal antibody M1C2 raised against a fragment of human and mouse menin. Cryostat tissue sections were ®xed in ice cold aceton and 4% phosphate buered paraformaldehyde, rinsed in PBS and blocked with 2% horse serum in PBS containing 0.1% Triton for 15 min. The antibody was diluted 1 : 2000 in PBS with 0.1% Triton and 1% BSA, and incubated over night at 48C. After several rinses in PBS, sections were incubated with the secondary antibody, Cy3 conjugated donkey anti rabbit (Jackson ImmunoResearch Inc. PA, USA) diluted 1 : 500 in PBS, for 1 h at room temperature. Incubation with preimmunization serum, or omission of the primary or secondary antibody steps served as negative controls. In these cases no speci®c labelling could be detected (not shown).
